Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123814192 | 12381419 | 2 | F | 201602 | 20160714 | 20160518 | 20160718 | EXP | TR-JNJFOC-20160512925 | JANSSEN | 0.00 | F | Y | 0.00000 | 20160718 | CN | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123814192 | 12381419 | 1 | PS | TOPAMAX | TOPIRAMATE | 1 | Oral | N | UNKNOWN | 20505 | 100 | MG | UNSPECIFIED | QD | |||||
| 123814192 | 12381419 | 2 | SS | RELPAX | ELETRIPTAN HYDROBROMIDE | 1 | Unknown | 0 | FILM COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123814192 | 12381419 | 1 | Migraine |
| 123814192 | 12381419 | 2 | Migraine |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123814192 | 12381419 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123814192 | 12381419 | Cerebral cyst | |
| 123814192 | 12381419 | Cerebral disorder | |
| 123814192 | 12381419 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123814192 | 12381419 | 2 | 2011 | 0 |